Regulation & law · 06/08/2010

DEA Corrects Notice on Scheduling of 2C-T-7 and N-Benzylpiperazine

The Drug Enforcement Administration (DEA) is correcting a notice of proposed rulemaking regarding the scheduling of N-Benzylpiperazine (BZP) and 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), which was published in the Federal Register on September 8, 2003. The correction addresses an error in the potency of BZP relative to amphetamine.